Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Bone Densitometer Systems Market size is projected to increase from USD 325.87 million in 2024 to USD 549.42 million by 2037, exhibiting a CAGR of over 4.1% during the forecast period, between 2025 and 2037. Currently in 2025, the industry revenue of bone densitometer systems is assessed at USD 335.22 million.
The major factor for the expansion of the global bone densitometer systems is the rising cases of bone disorders and related diseases including muscular dystrophy, and Duchene muscular dystrophy among the global population. Furthermore, if these diseases are not treated with effectiveness, they worsen over time and can lead to degenerative disease and orthopedic limitation which generates the need for bone densitometer systems. The National Library of Medicine published a report in 2018 that calculated the prevalence of osteoporosis to be more than 200 million people across the world. It also has been calculated that the occurrence of osteoporosis in women around the world is more than 23% and in men around the world was found to be almost 11%.
The growth of the bone densitometer systems market is attributed to growing cases of osteoporosis among the population, the surge in the incidence of accidents and traumas, and the development of new bone densitometer products by the major key players operating in the market. Furthermore, the increase in the number of product approvals by regulatory bodies is anticipated to provide remunerative opportunities for the expansion of the global bone densitometer systems during the forecast period.
Bone Densitometer Systems Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Musculoskeletal Diseases - Musculoskeletal diseases are a group of diseases that usually affects the joints, bones, and muscles, and aid the development of other bone diseases and their related illnesses. Treatment of such musculoskeletal conditions requires bone densitometer systems for an effective healing process of bones. As per the statistics shared by the World Health Organization (WHO) in 2022, approximately 1.71 billion people are affected by musculoskeletal conditions all over the world.
- Rapid Growth of the Orthopedic Devices Industry –This expansion of orthopedic devices is anticipated to generate favorable opportunities for an increase in the utilization rate of bone densitometer systems in treating bone diseases. For instance, the orthopedic device industry was expected to reach a total value of USD 45 billion by 2022.
- Rapid Escalation in Number of Bone Fractures – For instance, in 2019, there were more than 175 million cases of fractures and approximately 450 million cases of acute or long-term symptoms of a fracture.
- High Focus on Developing the Medical Devices Sector - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.
Challenges
- High Cost of Bone Densitometer Systems – Dual-energy X-ray Absorptiometry (DEXA) is one of the most common methods of bone densitometer systems for detecting bone mineral density. However, the cost of DEXA scanners is very much high owing to the integration of technologically advanced features and programs.
- Requirement of High Initial Investments
- Unavailability of Skilled Workforce for Utilization of Advanced Devices
Bone Densitometer Systems Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.1% |
|
Base Year Market Size (2024) |
USD 325.87 million |
|
Forecast Year Market Size (2037) |
USD 549.42 million |
|
Regional Scope |
|
Bone Densitometer Systems Segmentation
Application (Osteoporosis & Osteopenia, Cystic Fibrosis, Chronic Kidney Disease, Body Composition Measurement, Rheumatic Arthritis)
The osteoporosis & osteopenia segment is poised to account for bone densitometer systems market share of more than 32% by the end of 2037, due to rising cases of osteoporosis & osteopenia owing to the adoption of a sedentary lifestyle. Also, the burgeoning geriatric population who are more prone to osteoporosis & osteopenia is considered to positively contribute towards segment growth. As per the data provided by the World Health Organization (WHO), the share of the population of age 60 or above in the world increased from 1 billion to 1.4 billion in 2022 and is projected to double by 2050 reaching around 2.1 billion.
End-User (Hospitals, Clinics)
Hospital segment is expected to hold bone densitometer systems market share of over 46% by the end of 2037, attributed to the burgeoning of the geriatric population with a disability who requires full-time assistance and generally admits into hospitals. Moreover, the increasing investment in hospitals by governments of different nations, along with the rising healthcare expenditure, and the availability of the dedicated orthopedic section in the hospital. It was noted that spending on health care in the United States increased 2.7 percent in 2021 to USD 4.3 trillion, or USD 12,914 per person. Total expenditure on healthcare accounted for more than 18 percent of the region’s GDP.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Technology |
|
|
Scan |
|
|
Application |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportBone Densitometer Systems Industry - Regional Synopsis
North American Market Forecast
In bone densitometer systems market, North America region is estimated to hold over 35% revenue share by the end of 2037. The presence of the blooming healthcare industry and the rising cases of amputations owing to numerous reasons including bone fractures and various bone illnesses. It is estimated that in the United States, every year, nearly 170,000 amputation procedures take place and around 3.5 million people are estimated to with limb loss by the year 2050.
European Market Analysis
In bone densitometer systems market, Europe region is anticipated to account for revenue share of more than 24% by the end of 2037, on the back of increasing preference for minimally invasive medical procedures. An up-surged manufacturing process of novel tools and other assistive equipment can also be observed in the region which is anticipated to create a positive outlook for market growth.
Companies Dominating the Bone Densitometer Systems Landscape
- AMPall
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eurotec Medical Systems s.r.l.
- Medonica Co., Ltd.
- Scanflex Healthcare AB
- BeamMed Ltd.
- Swissray Global Healthcare Holding Ltd.
- Diagnostic Medical Systems Group
- OSI Systems, Inc.
- Hologic, Inc.
- GE Healthcare
- Echolight S.p.a
In the News
- Hologic, Inc. has partnered with DEXA+ to distribute the company’s Horizon DXA system for body composition measurement. This partnership is expected to expand Hologic, Inc.’s profile in body composition assessment.
- Echolight S.p.a has entered into a joint co-marketing agreement with Aurora Spine Corporation for assessing the patient’s bone mineral density (BMD) and the quality of bone microarchitecture independent of BMD.
Author Credits: Radhika Pawar
- Report ID: 3838
- Published Date: Mar 21, 2025
- Report Format: PDF, PPT
